PhytoHealth Corporation (4108.TW)

TWD 13.6

(8.37%)

Total Liabilities Summary of PhytoHealth Corporation

  • PhytoHealth Corporation's latest annual total liabilities in 2023 was 79.84 Million TWD , down -8.4% from previous year.
  • PhytoHealth Corporation's latest quarterly total liabilities in 2024 Q2 was 68.9 Million TWD , up 6.6% from previous quarter.
  • PhytoHealth Corporation reported annual total liabilities of 87.17 Million TWD in 2022, up 6.89% from previous year.
  • PhytoHealth Corporation reported annual total liabilities of 81.55 Million TWD in 2021, down -24.11% from previous year.
  • PhytoHealth Corporation reported quarterly total liabilities of 68.9 Million TWD for 2024 Q2, up 6.6% from previous quarter.
  • PhytoHealth Corporation reported quarterly total liabilities of 77.76 Million TWD for 2023 Q3, down -0.59% from previous quarter.

Annual Total Liabilities Chart of PhytoHealth Corporation (2023 - 2009)

Historical Annual Total Liabilities of PhytoHealth Corporation (2023 - 2009)

Year Total Liabilities Total Liabilities Growth
2023 79.84 Million TWD -8.4%
2022 87.17 Million TWD 6.89%
2021 81.55 Million TWD -24.11%
2020 107.47 Million TWD -17.46%
2019 130.2 Million TWD 5.4%
2018 123.53 Million TWD 7.69%
2017 114.7 Million TWD 4.65%
2016 109.6 Million TWD 153.75%
2015 43.19 Million TWD -57.13%
2014 100.75 Million TWD 19.11%
2013 84.58 Million TWD -15.73%
2012 100.37 Million TWD 14.65%
2011 87.55 Million TWD 3.4%
2010 84.67 Million TWD -17.49%
2009 102.62 Million TWD 0.0%

Peer Total Liabilities Comparison of PhytoHealth Corporation

Name Total Liabilities Total Liabilities Difference
Grape King Bio Ltd 3.88 Billion TWD 97.943%
Standard Chem & Pharm CO., LTD. 3.05 Billion TWD 97.383%
Maywufa Company Ltd. 794.91 Million TWD 89.955%
ScinoPharm Taiwan, Ltd. 1.35 Billion TWD 94.116%
Lotus Pharmaceutical Co., Ltd. 15.65 Billion TWD 99.49%
LIWANLI Innovation Co., Ltd. 50.66 Million TWD -57.617%
YungShin Global Holding Corporation 3.59 Billion TWD 97.78%
SCI Pharmtech, Inc. 1.59 Billion TWD 94.981%
Formosa Laboratories, Inc. 5.42 Billion TWD 98.528%
PharmaEssentia Corporation 3.32 Billion TWD 97.596%
Bora Pharmaceuticals Co., LTD. 13.28 Billion TWD 99.399%